Cost-effectiveness of public health practices: A literature review of public health interventions from the Mesoamerican Health Initiative;Costo-efectividad de prácticas en salud pública: Revisión bibliográfica de las intervenciones de la Iniciativa Mesoamericana de Salud

Salud Publica de Mexico

Volumn 53, Issue SUPPL. 3, 2011, Pages

  Valencia Mendoza, Atanacio ^a   Danese dlSantos, Laura G ^a   Sosa Rubí, Sandra G ^a   Aracena Genao, Belkis ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Cost effectiveness; Mesoamerica; Public health; Public health policy

Indexed keywords

ANIMAL; ARTICLE; BIBLIOMETRICS; CENTRAL AMERICA; CHILD; CHILD HEALTH CARE; COST; COST BENEFIT ANALYSIS; DENGUE; DEVELOPING COUNTRY; ECONOMICS; FEMALE; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; INTERNATIONAL COOPERATION; MALARIA; MALNUTRITION; MEXICO; MOSQUITO; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; STATISTICS;

ANIMALS; BIBLIOMETRICS; CENTRAL AMERICA; CHILD; CHILD HEALTH SERVICES; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DENGUE; DEVELOPING COUNTRIES; FEMALE; HEALTH PROMOTION; HUMANS; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; MALARIA; MALNUTRITION; MATERNAL HEALTH SERVICES; MEXICO; MOSQUITO CONTROL; PREGNANCY; PREVENTIVE HEALTH SERVICES; PUBLIC HEALTH; REPRODUCTIVE HEALTH SERVICES;

EID: 84858626340     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Proyecto Mesoamérica [sitio de internet]. Sistema Mesoamericano de Salud Pública (SMSP). El Salvador: SMSP, 2010. [consultado: 2010 agosto]. Disponible en: http://portal2.sre.gob.mx/mesoamerica/index.php?option=com_content&task=view&id=57&Itemid=45
2. Instituto Nacional de Salud Pública (INSP), Grupo Técnico de Nutrición (GTN). México: Instituto Nacional de Salud Pública, Iniciativa Mesoamericana de Salud, 2009.
3. Instituto Nacional de Salud Pública (INSP), Grupo Técnico de Salud Materna y Reproductiva (GTSMR). Reproductive, Maternal and Neonatal Health Master Plan. Iniciativa Mesoamericana de Salud, 2009.
4. World Health Organization (WHO), Choosing Interventions that are Cost Effective (CHOICE) [sitio de internet]. Geneva: WHO, 2009. [consultado: 2010 agosto]. Disponible en: http://www.who.int/choice/en/
5. Cairncross S, Valdmanis V. Water Supply, Sanitation, and Hygiene Promotion. En: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. eds. Disease control priorities in developing countries. 2a. edición. Nueva York: Oxford University Press, 2006;41:771-792.
6. Hoddinot J, Bassett L. Conditional Cash Transfer programs and Nutrition in Latin America: Assessment of impacts and strategies for improvement. Hunger-Free Latin America and the Caribbean Initiative, Working Paper 9. FAO; 2009.
7. Horton S, Sanghvi T, Phillips M, Fiedler J, Perez-Escamilla R, Lutter C, et al. Breastfeeding promotion and priority setting in health. Health Policy Plan 1996;11(2):156-168.
8. Caulfield LE, Richard SA, Rivera JA, Musgrove P, Black RE. Stunting, Wasting, and Micronutrient Deficiency Disorders. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. eds. Disease control priorities in developing countries. 2a edición. Nueva York: Oxford University Press, 2006;28:551-567.
9. Fiedler JL. A Cost Analysis of the Honduras Community-Based Integrated Child Care Program (Atención Integral a la Niñez-Comunitaria, AIN-C). Washington: World Bank, 2003.
10. Llanos A, Hertrampf E, Cortes F, Pardo A, Grosse SD, Uauy R. Costeffectiveness of a folic acid fortification program in Chile. Health Policy 2007;83(2-3):295-303.
11. Baltussen R, Knai C, Sharan M. Iron fortification and iron supplementation are cost-effective interventions to reduce iron deficiency in four subregions of the world. J Nutr 2004;134(10):2678-2684.
12. Horton S, Sheekar M, McDonald C, Mahal A, Brooks JK. Scaling Up Nutrition: What will it cost? Washington: The World Bank; 2010.
13. Sharieff W, Horton SE, Zlotkin S. Economic gains of a home fortification program: evaluation of "Sprinkles" from the provider's perspective. Can J Public Health 2006;97(1):20-23.
14. Graham WJ, Cairns J, Bhattacharya S, Bullough CHW, Quayyum Z, Rogo K. Maternal and Perinatal Conditions. En: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al, eds. Disease Control Priorities in Developing Countries. 2a edición. Nueva York: Oxford University Press, 2006:26.
15. Haws RA, Thomas AL, Bhutta ZA, Darmstadt GL. Impact of packaged interventions on neonatal health: a review of the evidence. Health Policy Plan 2007;22(4):193-215.
16. Darmstadt G, Bhutta Z, Cousens S, Adam T, Walker N, de Bernis L. Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet 2005;365(9463):977-988.
17. Jowett M. Cost-effective safe motherhood interventions in low-income countries: a review. Centre for Health Economics, University of York, 2000.
18. Suaya J, Shepard D, Chang MS, Caram M, Hoyer S, Socheat D, et al. Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti. Trop Med Int Health 2007;12(9):1026-1036.
19. Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, Mahoney RT, et al. Cost-effectiveness of a pediatric dengue vaccine. Vaccine 2004;22(9-10):1275-1280.
20. Akhavan D, Musgrove P, Abrantes A, d'A Gusmão R. Cost-effective malaria control in Brazil. Cost-effectiveness of a Malaria Control Program in the Amazon Basin of Brazil, 1988-1996. Soc Sci Med 1999;49(10):1385-1399.
21. Hanson K, Kikumbih N, Armstrong-Schellenberg J, Mponda H, Nathan R, Lake S, et al. Cost-effectiveness of social marketing of insecticide treated nets for malaria control in the United Republic of Tanzania. Bull World Health Organ 2003;81(4):269-276.
22. Mueller DH, Wiseman V, Bakusa D, Morgah K, Daré A, Tchamdja P. Cost-effectiveness analysis of insecticide-treated net distribution as part of the Togo Integrated Child Health Campaign. Malar J 2008 29;7:73.
23. Yukich JO, Zerom M, Ghebremeskel T, Tediosi F, Lengeler C. Costs and cost-effectiveness of vector control in Eritrea using insecticide-treated bed nets. Malar J 2009 30;8:51.
24. Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull World Health Organ 2009;87(2):123-129.
25. Utzinger J, Tozan Y, Singer BH. Efficacy and cost-effectiveness of environmental management for malaria control. Trop Med Int Health 2001;6(9):677-687.
26. Yukich JO, Lengeler C, Tediosi F, Brown N, Mulligan JA, Chavasse D, et al. Costs and consequences of large-scale vector control for malaria. Malar J 2008 17;7:258.
27. Goodman CA, Mnzava AE, Dlamini SS, Sharp BL, Mthembu DJ, Gumede JK. Comparison of the cost and cost-effectiveness of insecticide-treated bednets and residual house-spraying in KwaZulu-Natal, South Africa. Trop Med Int Health 2001;6(4):280-295.
28. Binka FN, Mensah OA, Mills A. The cost-effectiveness of permethrin impregnated bednets in preventing child mortality in Kassena-Nankana district of Northern Ghana. Health Policy 1997;41(3):229-239.
29. Sinha A, Constenla D, Valencia JE, O'Loughlin R, Gomez E, de la Hoz F, et al. Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis. Rev Panam Salud Publica 2008;24:304-313.
30. Constenla DO. Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay. Rev Panam Salud Publica 2008;24:101-112
31. Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet 2007;369:389-396.
32. Constenla D, Velazquez FR, Rheingans RD, Antil L, Cervantes Y. Economic impact of a rotavirus vaccination program in Mexico. Rev Panam Salud Publica 2009;25:481-490.
33. Constenla DO, Linhares AC, Rheingans RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr 2008;26:388-396.
34. de Soarez PC, Valentim J, Sartori AM, Novaes HM. Cost-effectiveness analysis of routine rotavirus vaccination in Brazil. Rev Panam Salud Publica 2008;23:221-230.
35. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007;21:205-216.
36. Constenla D, O'Ryan M, Navarrete MS, Antil L, Rheingans RD. Potential cost effectiveness of a rotavirus vaccine in Chile. Rev Med Chil 2006;134:679-688.
37. Constenla D, Perez-Schael I, Rheingans RD, Antil L, Salas H, Yarzabal JP. Assessment of the economic impact of the antiretroviral vaccine in Venezuela. Rev Panam Salud Publica 2006;20:213-222.
38. Valencia A, Bertozzi S, Gutierrez JP, Itzler R. Cost-effectiveness of introducing rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis 2008;8:103.
39. Waters HR, Penny ME, Creed-Kanashiro HM, Robert RC, Narro R, Willis J, et al. The cost-effectiveness of a child nutrition education programme in Peru. Health Policy Plan 2006;21(4):257-264.
40. Gross R, Gross U, Lechtig A, Lopez de Romana D. We know much about what to do but little about how to do it: experiences with a weekly multimicronutrient supplementation campaign. Food Nutr Bull 2006;27(4 Suppl Peru):S111-114.
41. Postma MJ, Londeman J, Veenstra M, de Walle HE, de Jong-van den Berg LT. Cost-effectiveness of periconceptional supplementation of folic acid. Pharm World Sci 2002;24(1):8-11.
42. Adam T, Lim SS, Mehta S, Bhutta ZA, Fogstad H, Mathai M, et al. Achieving the millennium development goals for health. BMJ 2005;331(7525):1107.
43. Griffiths U, Wolfson L, Quddus A, Younus M, Hafiz R. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. Bull World Health Organ 2004;82(9):643-651.
44. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricor J, et al. Cost-Effectiveness of Contraceptives in the United States. Contraception 2009;791):5-14.
45. Evans DB, Adam T, Tan-Torres ET, Lim SS, Cassels A, Evans TG. Achieving the millennium development goals for health. BMJ 2005;331(7525):1133-1136.
46. The World Bank. GDP per capita (current US$). [consultado 2010 agosto]. Disponible en: http://data.worldbank.org/indicator/NY.GDP.MKTP.CD.